Chandra Bhagat Pharma Limited (CBPL.BO)
INR 60.0
(8.33%)
INR 60.0
(8.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 36.55 Million INR | -3.2% |
| 2022 | 37.76 Million INR | -26.73% |
| 2021 | 51.54 Million INR | 15.71% |
| 2020 | 44.54 Million INR | 35.77% |
| 2019 | 32.81 Million INR | -27.5% |
| 2018 | 45.25 Million INR | 1.55% |
| 2017 | 44.56 Million INR | 11.4% |
| 2016 | 40 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | 8.64 Million INR | 0.0% |
| 2023 Q1 | 10.74 Million INR | 0.0% |
| 2023 Q2 | 8.64 Million INR | -19.53% |
| 2022 FY | - INR | -26.73% |
| 2022 Q2 | 8.13 Million INR | -47.67% |
| 2022 Q4 | 10.74 Million INR | 32.04% |
| 2022 Q1 | 15.55 Million INR | 0.0% |
| 2022 Q3 | 8.13 Million INR | 0.0% |
| 2021 Q3 | 10.22 Million INR | 0.0% |
| 2021 Q4 | 15.55 Million INR | 52.1% |
| 2021 FY | - INR | 15.71% |
| 2021 Q1 | 13.9 Million INR | 0.0% |
| 2021 Q2 | 10.22 Million INR | -26.48% |
| 2020 Q2 | 8.28 Million INR | 2.26% |
| 2020 FY | - INR | 35.77% |
| 2020 Q1 | 8.09 Million INR | -0.6% |
| 2020 Q3 | 8.28 Million INR | 0.0% |
| 2020 Q4 | 13.9 Million INR | 67.94% |
| 2019 Q2 | 8.35 Million INR | 0.0% |
| 2019 FY | - INR | -27.5% |
| 2019 Q4 | 8.14 Million INR | -2.52% |
| 2019 Q3 | 8.35 Million INR | 0.0% |
| 2018 FY | - INR | 1.55% |
| 2017 FY | - INR | 11.4% |
| 2016 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Checkpoint Trends Limited | 297.07 Thousand INR | -12206.19% |
| Everest Organics Limited | 118.72 Million INR | 69.208% |
| GUJARAT INJECT (KERALA) LTD. | 1.05 Million INR | -3373.019% |
| NATURO INDIABULL LIMITED | 14.68 Million INR | -148.914% |
| NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | -1125.982% |
| Rajnish Wellness Limited | 19.93 Million INR | -83.349% |
| Rama Vision Limited | 67.79 Million INR | 46.074% |
| Vivo Bio Tech Limited | 212.99 Million INR | 82.837% |